National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, 20892, United States
NCT Number: NCT02153931
Background:
- Studies show that Internet Support Groups (ISGs) can help parents of children with chronic conditions. Researchers want to find out if ISGs can help parents of a child with the genetic disorder Neurofibromatosis Type 1 (NF1).
Objective:
- To see if an ISG for parents with a child with NF1 can give the parents more social support and less anxiety.
Eligibility:
- Adults age 18 and older with a child (age 0 25 years) with NF1.
Design:
* Participants will register for the study on a website hosted by the Children s Tumor Foundation. * Participants will complete 5 questionnaires. These will be about their emotional well-being, their child s health status, and their contact information. * The ISG will include a Discussion Forum that participants can enter 24 hours a day, 7 days a week. A professional moderator will post questions and discussion topics. The moderator can also respond to questions. They will be a psychologist, a psychology associate, or a nurse-practitioner. Each one will be highly experienced at working with young people with NF1 and their families. * The ISG also will contain a chat room. Here participants can chat with other users in real time. The chat room will be open for one 90-minute session per week. * The ISG will remain open for 8 weeks. Then participants will retake 4 of the questionnaires from the beginning of the study. They will also complete 1 other questionnaire about their experiences with the ISG. Information from any messages participants post on the ISG website will be collected. * Three months after the ISG closes, participants will complete the questionnaires one final time.
Looking for future studies?
Notify Me18 year–99 year
All sexes
Observational
Bethesda, Maryland, 20892, United States
BACKGROUND:
OBJECTIVES:
ELIGIBILITY:
Eligible participants must self-report:
DESIGN:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
FOR PARENT PARTICPANT:
Participants must self-report being the primary caregiver of one or more children ages 0 to 25 with a confirmed diagnosis of NF1.
Participants must report being at least 18 years of age.
Participants must report living in the same home as the child(ren) with NF1 a majority of the time.
Participants must report having regular access to a computer and internet connection.
Participants will indicate they do not have any plans to start any other internet support group for parents of children with NF during the study time period.
Participants must have the ability to read and communicate in the English language.
Participants must have the ability to understand and the willingness to provide an online informed consent document.
Exclusion criteria
FOR PARENT PARTICIPANT:
Although individuals will be allowed to participate if they currently are part of another internet forum for NF, they will be excluded if they report they plan to start a new internet support group during the study period.
Time frame: 3 months
To determine the effects of an ISG on perceived social support among parents of a child with NF1 from baseline to 8 weeks and frombaseline to 3 months postintervention.
Time frame: 3 months
To determine the effects of an ISG on perceived social support among parents of a child with NF1 from baseline to 8 weeks and frombaseline to 3 months post-intervention.
Time frame: 2 years
National Cancer Institute (NCI)
Nih
Effects of an Internet Support Group for Parents of a Child With Neurofibromatosis Type 1
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04481048
Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders
Cincinnati, Ohio, United States
View Trial DetailsNCT03433183
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Fibrosarcoma
Washington D.C., District of Columbia, United States
View Trial DetailsNCT04481035
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn
Cincinnati, Ohio, United States
View Trial DetailsNCT05005845
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cutaneous Neurofibroma
Little Rock, Arkansas, United States
View Trial Details